LEGEND BIOTECH CORP-ADR
LEGN · NASDAQ
Updated at 2026-10-14 08:31:37
- Today's High
- $18.28
- Today’s Low
- $17.56
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $18.40
- Previous Close
- $17.80
- Volume
- 2.63M
- Market Cap
- $3.6B
- P/E Ratio
- --
- EPS
- $-0.25
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2101 COTTONTAIL LANE, SOMERSET, NJ, UNITED STATES, 08873
- Country
- US
- Listing Date
- 2020-06-04
- Fiscal Year End
- December
- Shares Outstanding
- 386.88M
- CIK
- 0001801198
- Website
- investors.legendbiotech.com
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology and other indications in North America and internationally.
Financial Metrics
Revenue
2026-06-30
$387.5M
2026-03-31
$305.1M
2025-12-31
$306.37M
2025-09-30
$272.33M
Operating Expenses
2026-06-30
$192.4M
2026-03-31
$179M
2025-12-31
$203.52M
2025-09-30
$200.47M
Net Income
2026-06-30
$33.2M
2026-03-31
-$54.3M
2025-12-31
-$30.81M
2025-09-30
-$39.68M
Net Profit Margin
2026-06-30
8.56%
2026-03-31
-17.79%
2025-12-31
-10.05%
2025-09-30
-14.57%
Earnings Per Share
2026-06-30
$0.09
2026-03-31
$-0.15
2025-12-31
$-0.16
2025-09-30
$-0.22
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$69.4M
2026-03-31
-$32M
2025-12-31
-$2.15M
2025-09-30
-$33.19M
Effective Tax Rate
2026-06-30
40.18%
2026-03-31
-2.25%
2025-12-31
-57.22%
2025-09-30
-1.57%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $387.5M | $305.1M | $306.37M | $272.33M |
| Operating Expenses | $192.4M | $179M | $203.52M | $200.47M |
| Net Income | $33.2M | -$54.3M | -$30.81M | -$39.68M |
| Net Profit Margin | 8.56% | -17.79% | -10.05% | -14.57% |
| Earnings Per Share | $0.09 | $-0.15 | $-0.16 | $-0.22 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $69.4M | -$32M | -$2.15M | -$33.19M |
| Effective Tax Rate | 40.18% | -2.25% | -57.22% | -1.57% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.